vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and GRAIL, Inc. (GRAL). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $30.1M, roughly 1.4× Dominari Holdings Inc.). GRAIL, Inc. runs the higher net margin — -227.5% vs -438.1%, a 210.6% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 14.0%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 27.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
DOMH vs GRAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $43.6M |
| Net Profit | $-131.8M | $-99.2M |
| Gross Margin | — | — |
| Operating Margin | -8.9% | -285.4% |
| Net Margin | -438.1% | -227.5% |
| Revenue YoY | 220.4% | 14.0% |
| Net Profit YoY | -12426.2% | -2.2% |
| EPS (diluted) | $-6.94 | $-2.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $43.6M | ||
| Q3 25 | $50.8M | $36.2M | ||
| Q2 25 | $34.1M | $35.5M | ||
| Q1 25 | $8.1M | $31.8M | ||
| Q4 24 | $9.4M | $38.3M | ||
| Q3 24 | $4.0M | $28.7M | ||
| Q2 24 | $6.2M | $32.0M | ||
| Q1 24 | $1.4M | $26.7M |
| Q4 25 | $-131.8M | $-99.2M | ||
| Q3 25 | $125.2M | $-89.0M | ||
| Q2 25 | $16.6M | $-114.0M | ||
| Q1 25 | $-32.5M | $-106.2M | ||
| Q4 24 | $1.1M | $-97.1M | ||
| Q3 24 | $-4.2M | $-125.7M | ||
| Q2 24 | $-6.1M | $-1.6B | ||
| Q1 24 | $-5.4M | $-218.9M |
| Q4 25 | -8.9% | -285.4% | ||
| Q3 25 | -3.1% | -346.2% | ||
| Q2 25 | -57.0% | -446.9% | ||
| Q1 25 | -394.6% | -482.5% | ||
| Q4 24 | 0.4% | -358.0% | ||
| Q3 24 | -79.1% | -640.5% | ||
| Q2 24 | -44.3% | -5133.8% | ||
| Q1 24 | -205.2% | -851.1% |
| Q4 25 | -438.1% | -227.5% | ||
| Q3 25 | 246.4% | -245.8% | ||
| Q2 25 | 48.7% | -320.7% | ||
| Q1 25 | -400.5% | -333.6% | ||
| Q4 24 | 11.4% | -253.8% | ||
| Q3 24 | -104.2% | -438.7% | ||
| Q2 24 | -99.1% | -4958.8% | ||
| Q1 24 | -398.0% | -819.3% |
| Q4 25 | $-6.94 | $-2.37 | ||
| Q3 25 | $7.27 | $-2.46 | ||
| Q2 25 | $1.12 | $-3.18 | ||
| Q1 25 | $-3.02 | $-3.10 | ||
| Q4 24 | $0.21 | $-1.49 | ||
| Q3 24 | $-0.67 | $-3.94 | ||
| Q2 24 | $-1.01 | $-51.06 | ||
| Q1 24 | $-0.91 | $-7.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $249.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $2.6B |
| Total Assets | $112.9M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $249.7M | ||
| Q3 25 | $176.2M | $126.9M | ||
| Q2 25 | $28.2M | $127.4M | ||
| Q1 25 | $18.9M | $133.9M | ||
| Q4 24 | $8.2M | $214.2M | ||
| Q3 24 | $7.2M | $853.6M | ||
| Q2 24 | $12.1M | $958.8M | ||
| Q1 24 | $7.1M | $199.7M |
| Q4 25 | $69.4M | $2.6B | ||
| Q3 25 | $210.2M | $2.2B | ||
| Q2 25 | $88.6M | $2.3B | ||
| Q1 25 | $42.4M | $2.4B | ||
| Q4 24 | $39.9M | $2.5B | ||
| Q3 24 | $38.3M | $2.6B | ||
| Q2 24 | $42.4M | $2.7B | ||
| Q1 24 | $47.7M | — |
| Q4 25 | $112.9M | $2.9B | ||
| Q3 25 | $223.4M | $2.6B | ||
| Q2 25 | $109.3M | $2.7B | ||
| Q1 25 | $52.3M | $2.8B | ||
| Q4 24 | $47.1M | $3.0B | ||
| Q3 24 | $43.4M | $3.1B | ||
| Q2 24 | $49.1M | $3.3B | ||
| Q1 24 | $52.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $-63.8M |
| Free Cash FlowOCF − Capex | — | $-63.9M |
| FCF MarginFCF / Revenue | — | -146.5% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-299.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $-63.8M | ||
| Q3 25 | $-4.9M | $-63.2M | ||
| Q2 25 | $-353.0K | $-77.0M | ||
| Q1 25 | $1.2M | $-95.0M | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-4.7M | $-104.6M | ||
| Q2 24 | $1.4M | $-171.8M | ||
| Q1 24 | $-8.6M | $-207.3M |
| Q4 25 | — | $-63.9M | ||
| Q3 25 | — | $-63.6M | ||
| Q2 25 | — | $-77.3M | ||
| Q1 25 | — | $-95.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-105.6M | ||
| Q2 24 | — | $-173.2M | ||
| Q1 24 | — | $-209.8M |
| Q4 25 | — | -146.5% | ||
| Q3 25 | — | -175.8% | ||
| Q2 25 | — | -217.6% | ||
| Q1 25 | — | -298.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -368.4% | ||
| Q2 24 | — | -541.7% | ||
| Q1 24 | — | -785.3% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 9.5% |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
